Clinical Trial Update: Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for the ResToP study evaluating reinduction and a second stop of ponatinib therapy in chronic phase chronic myeloid leukemia patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia Chronic Phase

Drugs mentioned

• Iclusig (ponatinib) (ponatinib)

Snippet

Sponsor: Fundacion CRIS de Investigación para Vencer el Cáncer | Conditions: Chronic Myeloid Leukemia, Chronic Phase | Phase 2 | Status: ACTIVE_NOT_RECRUITING